NEW YORK, NY / ACCESSWIRE / October 23, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
PLAN Shareholders Click Here: https://www.zlk.com/pslra-1/anaplan-inc-information-request-form?prid=10417&wire=1
NXTC Shareholders Click Here: https://www.zlk.com/pslra-1/nextcure-inc-information-request-form?prid=10417&wire=1
LOOP Shareholders Click Here: https://www.zlk.com/pslra-1/loop-industries-inc-loss-submission-form?prid=10417&wire=1
* ADDITIONAL INFORMATION BELOW *
Anaplan Inc. (NYSE:PLAN)
PLAN Lawsuit on behalf of: investors who purchased November 21, 2019 - February 26, 2020
Lead Plaintiff Deadline: October 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/anaplan-inc-information-request-form?prid=10417&wire=1
According to the filed complaint, during the class period, Anaplan Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was undergoing sales organization and execution challenges; (2) these organizational challenges were causing the Company to miss on closing very important large deals; and (3) as a result, Anaplan's financial guidance for "calculated billings growth" was baseless and unattainable. Further, while in possession of this material non-public information, Anaplan insiders dumped approximately $30 million worth of Anaplan stock at artificially inflated prices.
Nextcure, Inc. (NASDAQ:NXTC)
The Nextcure lawsuit was filed on behalf of investors who purchased Nextcure, Inc. (NASDAQ: NXTC) securities: (1) between November 5, 2019, and July 14, 2020, inclusive; and/or (2) pursuant or traceable to the company's secondary public offering declared effective on November 14, 2019.
Lead Plaintiff Deadline: November 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/nextcure-inc-information-request-form?prid=10417&wire=1
Throughout the class period, defendants' statements were materially misleading because the data Defendants possessed on its principle product candidate, NC318, showed a lack of efficacy and objective responses. Had the truth been revealed, the market would have seen that NC318 was not, in fact, effective in treating most tumor types, that the NC318 application was proving to be limited (if even useful at all), and, as a result, there was a significant realizable risk that NC318 would not be nearly as popular as then-existing blockbuster drugs, such as Keytruda.
Loop Industries, Inc. (NASDAQ:LOOP)
LOOP Lawsuit on behalf of: investors who purchased September 24, 2018 - October 12, 2020
Lead Plaintiff Deadline: December 14, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/loop-industries-inc-loss-submission-form?prid=10417&wire=1
According to the filed complaint, during the class period, Loop Industries, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Loop scientists were encouraged to misrepresent the results of Loop's purportedly proprietary process; (2) Loop did not have the technology to break PET down to its base chemicals at a recovery rate of 100%; (3) as a result, the Company was unlikely to realize the purported benefits of Loop's announced partnerships with Indorama Ventures Public Company Limited and thyssenkrupp Industrial Solutions; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington, D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
https://www.zlk.com
SOURCE: Levi & Korsinsky, LLP